{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:18:45Z","timestamp":1775132325033,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bioorg.2022.106228","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T21:44:17Z","timestamp":1667511857000},"page":"106228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Structure-activity relationship study of a series of nucleoside derivatives bearing sulfonamide scaffold as potent and selective PRMT5 inhibitors"],"prefix":"10.1016","volume":"130","author":[{"given":"Yuting","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaixin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zekun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2022.106228_b0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/14789450.2017.1275573","article-title":"The story of protein arginine methylation: characterization, regulation, and function","volume":"14","author":"Peng","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.bioorg.2022.106228_b0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cbpa.2017.06.013","article-title":"Recent progress in developing selective inhibitors of protein methyltransferases","volume":"39","author":"Kaniskan","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"Pt 5","key":"10.1016\/j.bioorg.2022.106228_b0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1242\/jcs.039933","article-title":"Human protein arginine methyltransferases in vivo\u2013distinct properties of eight canonical members of the PRMT family","volume":"122","author":"Herrmann","year":"2009","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2022.106228_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","article-title":"Protein arginine methylation in mammals: who, what, and why","volume":"33","author":"Bedford","year":"2009","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.bioorg.2022.106228_b0025","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1074\/jbc.M111.336271","article-title":"Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming omega-NG-monomethylated arginine residues","volume":"287","author":"Zurita-Lopez","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2022.106228_b0030","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00018-009-0010-x","article-title":"The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans","volume":"66","author":"Wolf","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"issue":"35","key":"10.1016\/j.bioorg.2022.106228_b0035","doi-asserted-by":"crossref","first-page":"32971","DOI":"10.1074\/jbc.M105412200","article-title":"PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins","volume":"276","author":"Branscombe","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.bioorg.2022.106228_b0040","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1073\/pnas.1209814109","article-title":"Crystal structure of the human PRMT5:MEP50 complex","volume":"109","author":"Antonysamy","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.bioorg.2022.106228_b0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.tibs.2011.09.001","article-title":"Versatility of PRMT5-induced methylation in growth control and development","volume":"36","author":"Karkhanis","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2022.106228_b0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molcel.2005.04.003","article-title":"Arginine methylation an emerging regulator of protein function","volume":"18","author":"Bedford","year":"2005","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.bioorg.2022.106228_b0055","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ncb1802","article-title":"Arginine methylation regulates the p53 response","volume":"10","author":"Jansson","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2022.106228_b0060","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00018-015-1847-9","article-title":"The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond","volume":"72","author":"Stopa","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"20","key":"10.1016\/j.bioorg.2022.106228_b0065","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1128\/MCB.00923-08","article-title":"Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells","volume":"28","author":"Wang","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2022.106228_b0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1042\/BJ20120768","article-title":"Protein arginine methyltransferase 5 is essential for growth of lung cancer cells","volume":"446","author":"Gu","year":"2012","journal-title":"Biochem. J."},{"issue":"21","key":"10.1016\/j.bioorg.2022.106228_b0075","doi-asserted-by":"crossref","first-page":"9429","DOI":"10.1021\/acs.jmedchem.8b00598","article-title":"Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106228_b0080","doi-asserted-by":"crossref","unstructured":"F. Yan, L. Alinari, M.E. Lustberg, L.K. Martin, H.M. Cordero-Nieves, Y. Banasavadi-Siddegowda, S. Virk, J. Barnholtz-Sloan, E.H. Bell, J. Wojton, N.K. Jacob, A. Chakravarti, M.O. Nowicki, X. Wu, R. Lapalombella, J. Datta, B. Yu, K. Gordon, A. Haseley, J.T. Patton, P.L. Smith, J. Ryu, X. Zhang, X. Mo, G. Marcucci, G. Nuovo, C.H. Kwon, J.C. Byrd, E.A. Chiocca, C. Li, S. Sif, S. Jacob, S. Lawler, B. Kaur, R.A. Baiocchi, Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma, Cancer Res 74(6) (2014) 1752-65.","DOI":"10.1158\/0008-5472.CAN-13-0884"},{"key":"10.1016\/j.bioorg.2022.106228_b0085","doi-asserted-by":"crossref","unstructured":"B. Gyorffy, P. Surowiak, J. Budczies, A. Lanczky, Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer, PLoS One 8(12) (2013) e82241.","DOI":"10.1371\/journal.pone.0082241"},{"issue":"3","key":"10.1016\/j.bioorg.2022.106228_b0090","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/acs.jmedchem.1c01900","article-title":"Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5*MTA Complex for the Treatment of MTAP-Deleted Cancers","volume":"65","author":"Smith","year":"2022","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2022.106228_b0095","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nchembio.1810","article-title":"A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models","volume":"11","author":"Chan-Penebre","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2022.106228_b0100","unstructured":"Duncan, K. W.; Chesworth, R.; Boriack-Sjodin, P. A.; Munchhof, M. J.; Jin, L. PRMT5 inhibitors and uses thereof. U.S. Patent US8,993,555."},{"key":"10.1016\/j.bioorg.2022.106228_b0105","doi-asserted-by":"crossref","unstructured":"D. Brehmer, L. Beke, T. Wu, H.J. Millar, C. Moy, W. Sun, G. Mannens, V. Pande, A. Boeckx, E. van Heerde, T. Nys, E.M. Gustin, B. Verbist, L. Zhou, Y. Fan, V. Bhargava, P. Safabakhsh, P. Vinken, T. Verhulst, A. Gilbert, S. Rai, T.A. Graubert, F. Pastore, D. Fiore, J. Gu, A. Johnson, U. Philippar, B. Morschhauser, D. Walker, D. De Lange, V. Keersmaekers, M. Viellevoye, G. Diels, W. Schepens, J.W. Thuring, L. Meerpoel, K. Packman, M.V. Lorenzi, S. Laquerre, Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity, Mol Cancer Ther 20(12) (2021) 2317-2328.","DOI":"10.1158\/1535-7163.MCT-21-0367"},{"issue":"7","key":"10.1016\/j.bioorg.2022.106228_b0110","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1021\/acsmedchemlett.8b00014","article-title":"LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity","volume":"9","author":"Bonday","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106228_b0115","doi-asserted-by":"crossref","unstructured":"K. Jensen-Pergakes, J. Tatlock, K.A. Maegley, I.J. McAlpine, M. McTigue, T. Xie, C.P. Dillon, Y. Wang, S. Yamazaki, N. Spiegel, M. Shi, A. Nemeth, N. Miller, E. Hendrickson, H. Lam, J. Sherrill, C.Y. Chung, E.A. McMillan, S.K. Bryant, P. Palde, J. Braganza, A. Brooun, Y.L. Deng, V. Goshtasbi, S.E. Kephart, R.A. Kumpf, W. Liu, R.L. Patman, E. Rui, S. Scales, M. Tran-Dube, F. Wang, M. Wythes, T.A. Paul, SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance, Mol Cancer Ther 21(1) (2022) 3-15.","DOI":"10.1158\/1535-7163.MCT-21-0620"},{"issue":"7","key":"10.1016\/j.bioorg.2022.106228_b0120","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1021\/acs.jmedchem.0c02083","article-title":"The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer","volume":"64","author":"Quiroz","year":"2021","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2022.106228_b0125","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/acsmedchemlett.0c00355","article-title":"A Chemical Probe for the Methyl Transferase PRMT5 with a Novel Binding Mode","volume":"11","author":"Pande","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.bioorg.2022.106228_b0130","doi-asserted-by":"crossref","DOI":"10.1039\/c2sc20536j","article-title":"Trimethyl lock: a trigger for molecular release in chemistry, biology, and pharmacology","volume":"3","author":"Levine","year":"2012","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2022.106228_b0135","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/s41467-020-16271-z","article-title":"Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response","volume":"11","author":"Szewczyk","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822006344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822006344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:35:56Z","timestamp":1758616556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822006344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":27,"alternative-id":["S0045206822006344"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106228","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship study of a series of nucleoside derivatives bearing sulfonamide scaffold as potent and selective PRMT5 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106228"}}